XALKORI

Capsule, hard, 250mg
RxActive license

Active substance (INN)

crizotinib

Pharmaceutical form

Pharmaceutical formCapsule, hard
Strength250mg
PackagingUkupno 60 kapsula tvrdih u blisteru (6x10) u kartonskoj kutiji
ManufacturerPfizer Manufacturing Deutschland GmbH, Germany
Therapeutic groupAntineoplastic and immunomodulating agents (L01ED01)
Marketing authorization holder"EVROPA LEK PHARMA" DOO PODGORICA
Authorization dateJune 20, 2025

Analogs in Montenegro

1

Other medicines with the same active substance

XALKORIRx
Capsule, hard, 200mgPfizer Manufacturing Deutschland GmbH
Source: CInMED register